Background: Previous work has proposed that celecoxib may be able to enhance the effects
of radiotherapy. However, the underlying mechanism of this activity has not yet been …

The current study aimed to identify the radiosensitizing effect of celecoxib, a selective
cyclooxygenase-2 (COX-2) inhibitor, in combination with radiotherapy in non-small-cell lung …

To characterize the radiation-enhancing effects on human cancer cells and underlying
mechanisms of celecoxib, a cyclooxygenase (COX)-2 selective inhibitor, and to ascertain …

Abstract Different cyclooxygenase (COX)-2 inhibitors were known to cause different cell
cycle changes. We investigated whether this different effect on cell cycle change was due to …

OBJECTIVE: The effects of celecoxib, a selective cyclo-oxygenase-2 (COX-2) inhibitor, on
HeLa cervical cancer cell growth and radiosensitivity were investigated. METHODS …

Celecoxib is a selective cyclooxygenase-2 (COX-2) inhibitor with antitumor and
antiangiogenic activities. To investigate the effects of celecoxib on nasopharyngeal …

Aim: To investigate the mechanisms underlying the anticancer effect of celecoxib on
nasopharyngeal carcinoma (NPC). Methods: NPC cell lines, HNE1 and CNE1-LMP1, were …

Radiotherapy resistance is an enduring major setback in lung cancer therapy, and is
responsible for a large proportion of treatment failures. In previous years, cyclooxygenase‑2 …

Objectives The role of celecoxib in preventing and treating tumors has attracted broad
attention in recent years because of its selective and specific inhibition of COX‐2 activity. We …

BACKGROUND: Radiosensitivity by blocking the epidermal growth factor receptor and
cyclooxygenase-2 pathways with erlotinib and celecoxib in A549 human lung cancer cell …